Nanotextured Substrate for Cardiomyocyte Maturation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for engineering cardiac tissue in vitro fail to accurately replicate the nanoscale cues of the extracellular matrix, leading to loss of native organization and compromised physiological properties in cardiomyocyte cultures, hindering the development of functional and therapeutic cardiac tissue constructs.
Innovation Solution
A nanotextured polymer platform with an array of parallel grooves and ridges is used to organize immature muscle cells in an anisotropic manner, mimicking the native cardiac tissue environment, enhancing maturation and functional properties of cardiomyocytes, and allowing for scalable and high-throughput tissue generation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If common culturing techniques are used for cardiomyocytes in vitro, then cell culture is simple and scalable, but the cells lose native organization and adopt random distribution, compromising physiological properties
Solution Approach 1:
The patent changes the physical parameter of the substrate surface by introducing nanoscale topographical features (grooves and ridges with specific dimensions) to alter cell behavior. This nanotexturing transforms the flat substrate into a structured surface that guides cell orientation and organization, resolving the contradiction between ease of culture and physiological fidelity.
Solution Approach 2:
The patent applies local quality by creating specific nanoscale regions with distinct topographical features (grooves of 50-500 nm width, ridges of 50-500 nm width) that locally influence cell behavior. These localized structural variations guide cardiomyocyte alignment and organization without requiring complete redesign of the entire culture system.
2Manufacturing precision
If 2D and 3D substrata with 10 μm feature size are used to direct cardiomyocytes into anisotropic arrangements, then cell organization is improved, but the structure fails to replicate the nanoscale cues provided by the ECM
Solution Approach 1:
The patent transitions from microscale (10 μm) to nanoscale (50-500 nm) topographical features, adding a new dimensional scale to the substrate design. This dimensional change enables replication of ECM nanoscale cues that were previously inaccessible, allowing more precise control of cell organization at the physiologically relevant scale.
Solution Approach 2:
The patent changes the critical parameter of feature size from micrometers to nanometers, creating topographical structures that match the natural scale of ECM interactions. This parameter change enables the substrate to provide authentic nanoscale mechanical and topographical cues that guide cardiomyocyte behavior more accurately.
3Reliability
If nanofabrication techniques are used to create scalable scaffolding materials, then structural and mechanical cues are improved, but the complexity of fabrication increases
Solution Approach 1:
The patent segments the fabrication process into distinct stages: first creating the nanotextured substrate using nanofabrication, then coating with ECM proteins, and finally seeding cells. This segmentation allows each step to be optimized independently, managing overall fabrication complexity while maintaining structural fidelity.
Solution Approach 2:
The patent performs preliminary action by pre-fabricating the nanotextured substrate structure before cell seeding. The nanoscale topography and ECM protein coating are established in advance, creating a ready-to-use platform that simplifies the overall tissue engineering process and ensures consistent structural cues are present before cells are introduced.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nanotextured platform effectively matures cardiomyocytes into a more adult-like phenotype, enabling the creation of functional engineered cardiac tissue that mimics native cardiac tissue in terms of structure and function, suitable for therapeutic applications and drug screening.
Implementation Method 1
a nanotextured array of parallel grooves and ridges that organizes cultured cardiomyocytes in an anisotropic manner
Data Source
AI summary
The present invention generally relates to the field of cell growth and tissue engineering, in particular, tissue engineered compositions comprising a nanotextured substrate which is structurally configured for growth of cells in an anatomically correct adult phenotype in vitro. In particular, described herein are nanotextured substrates which are structurally configured for the anisotropic organization, maturation, and growth of in vitro-differentiated muscle cells, such as cardiomyocytes, and methods for the production and use thereof in varying sizes, nanotextures and substrate rigidities. In vitro-differentiated cardiomyocytes grown on the nanotextured substrates described herein are better-differentiated and more closely mimic adult cardiac tissue than the same cells grown on a non-textured substrate of the same composition. The nanotextured substrate/cell constructs provide a platform for screening to predict the effect of test agents or drugs on, for example, human cardiac tissue, including patient-derived tissue, or for the identification of agents that effect various cardiac functional parameters.